Jul 1, 2026 09:07AM
Jul 1, 2026 09:06AM
Jul 1, 2026 08:37AM
Jul 1, 2026 08:36AM
Jun 29, 2026 04:06PM
Jun 29, 2026 04:05PM
Jun 2, 2026 07:37AM Wedbush Upgrades Abivax (ABVX) to Neutral
Jun 1, 2026 04:37PM
Jun 1, 2026 04:05PM
Jun 1, 2026 04:05PM
May 22, 2026 04:05PM
May 22, 2026 04:05PM
Apr 22, 2026 04:05PM
Mar 23, 2026 04:05PM Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Feb 21, 2026 06:00AM
Jan 7, 2026 04:05PM
Dec 17, 2025 04:05PM
Dec 17, 2025 04:05PM
Dec 15, 2025 04:07PM
Nov 3, 2025 04:05PM
Nov 3, 2025 04:05PM Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely
Oct 6, 2025 04:55AM
Oct 6, 2025 04:00AM
Oct 5, 2025 11:00AM
Sep 29, 2025 04:05PM
Sep 29, 2025 04:05PM
Sep 23, 2025 04:05PM
Sep 23, 2025 04:05PM Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
Jul 23, 2025 04:17PM
Jul 23, 2025 04:15PM
Jul 23, 2025 07:54AM
Jul 22, 2025 04:05PM
Jul 22, 2025 04:05PM
Apr 29, 2025 04:05PM
Apr 22, 2025 04:05PM Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Apr 22, 2025 04:00PM
Apr 22, 2025 04:00PM
Jan 28, 2025 02:30AM
Jan 9, 2025 11:35AM
Jan 2, 2025 12:51PM
Dec 23, 2024 04:07PM
Dec 23, 2024 04:05PM Abivax Announces a Change to the Composition of its Board of Directors
Nov 19, 2024 04:31PM
Nov 19, 2024 04:30PM
Nov 14, 2024 04:01PM
Nov 13, 2024 04:03PM
Nov 13, 2024 04:01PM
Oct 7, 2024 04:01PM
Oct 3, 2024 04:01PM Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
Oct 3, 2024 06:00AM

324,764 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All